Skip to main content

Table 1 Disease latency and frequency

From: Impairment of alternative splice sites defining a novel gammaretroviral exon within gagmodifies the oncogenic properties of Akv murine leukemia virus

Virus

Average latency period (days)

Frequency of mice developing hematopoitic tumors

Akv-wt

184 ± 26

40/40

Akv-CD

201 ± 30

17/19

Akv-EH

184 ± 34

17/18

Akv-CDH

190 ± 46

14/16